The two active compounds identified in this work are structurally similar with conserving key interactions against SER 582, ASP 764, and SER1292 on DNMT1 in the presence of their cofactor SAM. The MD simulations suggest that the DNMT1 inhibition of 12 and 13 is associated with the conformational changes of the CXXC and autoinhibition domains.